References
- Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME. Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol. 2014;47(1):26–37. doi:https://doi.org/10.1007/s12016-013-8365-z.
- Son JH, Park SY, Cho YS, Chung BY, Kim HO, Park CW. Immediate hypersensitivity reactions induced by triamcinolone in a patient with atopic dermatitis. J Korean Med Sci. 2018;33(12):12. doi:https://doi.org/10.3346/jkms.2018.33.e87.
- Baeck M, Marot L, Nicolas J, Pilette C, Tennstedt D, Goossens A. Allergic hypersensitivity to topical and systemic corticosteroids: a review. Allergy. 2009;64(7):978–994. doi:https://doi.org/10.1111/j.1398-9995.2009.02038.x.
- Jang EJ, Jin HJ, Nam YH, Kim JH, Ye Y-M, Park H-S. Acute urticaria induced by oral methylprednisolone. Allergy Asthma Immunol Res. 2011;3(4):277–279. doi:https://doi.org/10.4168/aair.2011.3.4.277.
- Mendelson LM, Hamburger RN, Melfrer E. Anaphylaxis-like reactions to corticosteroid therapy. J Allergy Clin Immunol. 1973;54:7.
- Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol. 1998;25:1995–2002.
- Borja JM, Galindo PA, Feo F, Gomez E. Urticaria to methylprednisolone sodium hemisuccinate. Allergy. 2001;56:791.
- Lauerma AI, Reitamo S. Contact allergy to corticosteroids. J Am Acad Dermatol. 1993;28:618–622.
- Dooms‐Goossens A, Andersen KE, Brandao FM, et al. Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis. 1996;35(1):40–44.
- Bennett ML, Fountain JM, McCarty MA, Sherertz EF. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma. Am J Contact Dermat. 2001;12(4):193–196. doi:https://doi.org/10.1053/ajcd.2001.28690.
- Comaish S. A case of hypersensitivity to corticosteroids. Br J Dermatol. 1969;81(12):919–925. doi:https://doi.org/10.1111/j.1365-2133.1969.tb15974.x.
- Patel A, Bahna SL. Immediate hypersensitivity reactions to corticosteroids. Ann Allergy Asthma Immunol. 2015;115(3):178–182. doi:https://doi.org/10.1016/j.anai.2015.06.022.
- Kamm GL, Hagmeyer KO. Allergic-type reactions to corticosteroids. Ann Pharmacother. 1999;33(4):451–460. doi:https://doi.org/10.1345/aph.18276.
- Otani IM, Banerji A. Immediate and delayed hypersensitivity reactions to corticosteroids: evaluation and management. Curr Allergy Asthma Rep. 2016;16(3):18. doi:https://doi.org/10.1007/s11882-016-0596-7.
- Räsänen L, Hasan T. Allergy to systemic and intralesional corticosteroids. Br J Dermatol. 1993;128(4):407–411. doi:https://doi.org/10.1111/j.1365-2133.1993.tb00200.x.
- Garner LA, Cruz JPD. Worsening of a recurrent facial eruption despite treatment. Dermatitis. 1999;10(2):81–82. doi:https://doi.org/10.1016/S1046-199X(99)90004-0.
- Goossens A, Matura M. Contact allergy to corticosteroids. Allergy. 2000;55:698–704. doi:https://doi.org/10.1034/j.1398-9995.2000.00121.x.
- Beynel P, Guérin J-C. Réactions anaphylactiques aux corticostéroïdes systémiques. Rev Mal Respir. 1999;16:529–537.
- Berbegal L, DeLeon FJ, Silvestre JF. Reacciones de hipersensibilidad a corticoides. Actas Dermosifiliogr. 2016;107(2):107–115. doi:https://doi.org/10.1016/j.ad.2015.09.012.
- Burgdorff T, Venemalm L, Vogt T, Landthaler M, Stolz W. IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. Ann Allergy Asthma Immunol. 2002;89(4):425–428. doi:https://doi.org/10.1016/S1081-1206(10)62046-7.
- McDougal BA, Whittier FC, Cross DE. Sudden death after bolus steroid therapy for acute rejection. Transplant Proc. 1976;8(3):493–496.
- Thompson JF, Chalmers DHK, Wood RFM, Kirkham SR, PJ M. Sudden death following high-dose intravenous methylprednisolone. Transplantation. 1983;36(5):594–596. doi:https://doi.org/10.1097/00007890-198311000-00028.
- Bundgaard H. The possible implication of steroid-glyoxal degradation products in allergic reactions to corticosteroids. Arch Pharm Chem Sci Ed. 1980;8:83–90.
- Murrieta-Aguttes M, Michelen V, Leynadier F, Duarte-Risselin C, Halpern GM, Dry J. Systemic allergic reactions to corticosteroids. J Asthma. 1991;28(5):329–339. doi:https://doi.org/10.3109/02770909109089460.
- Baeck M, Goossens AN. Patients with airborne sensitization/contact dermatitis from budesonide‐containing aerosols ‘by. Contact Dermatitis. 2009;61(1):1–8. doi:https://doi.org/10.1111/j.1600-0536.2009.01575.x.
- Coopman S, Degreef H, Dooms‐Goossens A. Identification of cross‐reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989;121(1):27–34. doi:https://doi.org/10.1111/j.1365-2133.1989.tb01396.x.
- Baeck M, Chemelle JA, Goossens A, Nicolas JF, Terreux R. Corticosteroid cross‐reactivity: clinical and molecular modelling tools. Allergy. 2011;66(10):1367–1374. doi:https://doi.org/10.1111/j.1398-9995.2011.02666.x.
- Rasse C, Terreux R, Goossens A. C-16-methyl corticosteroids are far less allergenic than the non-methylated molecules. Contact Dermatitis. 2011 Jun;64(6):305-12. doi: https://doi.org/10.1111/j.1600-0536.2011.01874.x.
- Baeck M, De Potter P, Goossens A. Allergic contact dermatitis following ocular use of corticosteroids. J Ocul Pharmacol Ther. 2011;27(1):83–92. doi:https://doi.org/10.1089/jop.2010.0084.
- Whitmore SE. Delayed systemic allergic reactions to corticosteroids. Contact Dermatitis. 1995;32(4):193–198. doi:https://doi.org/10.1111/j.1600-0536.1995.tb00668.x.
- Alani SD, Alani MD. Allergic contact dermatitis and conjunctivitis to corticosteroids. Contact Dermatitis. 1976;2(6):301–304. doi:https://doi.org/10.1111/j.1600-0536.1976.tb03064.x.
- Mathias CGT, Robertson DB. Delayed hypersensitivity to a corticosteroid suspension containing methylprednisolone: two cases of conjunctival inflammation after retrobulbar injection. Arch Dermatol. 1985;121(2):258–261. doi:https://doi.org/10.1001/archderm.1985.01660020116033.
- Fraunfelder FW, Rosenbaum JT. Drug-induced uveitis. Drug Saf. 1997;17(3):197–207. doi:https://doi.org/10.2165/00002018-199717030-00005.
- Cordero-Coma M, Salazar-Méndez R, Garzo-García I, Yilmaz T. Drug-induced uveitis. Expert Opin Drug Saf. 2015;14(1):111–126. doi:https://doi.org/10.1517/14740338.2015.972363.
- Krupin T, LeBlanc RP, Becker B, Kolker AE, Podos SM. Uveitis in association with topically administered corticosteroid. Am J Ophthalmol. 1970;70(6):883–885. doi:https://doi.org/10.1016/0002-9394(70)92463-3.
- Ventura MT, Calogiuri GF, Matino MG, et al. Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients. Br J Dermatol. 2003;148(1):139–141. doi:https://doi.org/10.1046/j.1365-2133.2003.05061.x.
- Mathias CGT, Maibach HI, Ostler HB, Nelson W. Delayed hypersensitivity to retrobulbar injections of methylprednisolone acetate. Am J Ophthalmol. 1978;86(6):816–819. doi:https://doi.org/10.1016/0002-9394(78)90128-9.
- Aranda A, Mayorga C, Ariza A, et al. IgE‐mediated hypersensitivity reactions to methylprednisolone. Allergy. 2010;65(11):1376–1380. doi:https://doi.org/10.1111/j.1398-9995.2010.02386.x.
- Wilkinson SM, English JSC. Hydrocortisone sensitivity: a prospective study of the value of tixocortol pivalate and hydrocortisone acetate as patch test markers. Contact Dermatitis. 1991;25(2):132–133. doi:https://doi.org/10.1111/j.1600-0536.1991.tb01809.x.
- Lauerma AI. Screening for corticosteroid contact sensitivity: comparison of tixocortol pivalate, hydrocortisone‐17‐butyrate and hydrocortisone. Contact Dermatitis. 1991;24(2):123–130. doi:https://doi.org/10.1111/j.1600-0536.1991.tb01664.x.
- Isaksson M, Bruze M, Björkner B, Hindsén M, Svensson L. The benefit of patch testing with a corticosteroid at a low concentration. Am J Contact Dermat. 1999;10:31–33.
- Isaksson M. Corticosteroid contact allergy-the importance of late readings and testing with corticosteroids used by the patients. Contact Dermatitis. 2007;56:56–57.
- Isaksson M, Dooms-Goossens AN. Contact allergens–what’s new? Corticosteroids. Clin Dermatol. 1997;15:527–531.
- Fieß A, Halstenberg S, Fellas A, Frisch I, Steinhorst UH. Anaphylactic reaction to intravenous corticosteroids in the treatment of ocular toxoplasmosis: a case report. J Med Case Rep. 2014;8:110.
- Erdmann SM, Abuzahra F, Merk HF, Schroeder A, Baron JM. Anaphylaxis induced by glucocorticoids. J Am Board Fam Pract. 2005;18:143–146.
- Baeck M, Chemelle JA, Rasse C, Terreux R, Goossens A. C(16)-methyl corticosteroids are far less allergenic than the non-methylated molecules. Contact Dermatitis. 2011;64(6):305–312. doi:https://doi.org/10.1111/j.1600-0536.2011.01874.x.
- Khalifa Y, Loh AR, Acharya NR. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2009;17:431–433.
- Karacorlu M, Karacorlu SA, Ozdemir H. Intravitreal Triamcinolone Acetonide in Vogt-Koyanagi-Harada Syndrome. London, England: SAGE Publications Sage UK; 2006.
- Moreker MR, Lodhi SA, Pathengay A. Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease. Indian J Ophthalmol. 2007;55:479.
- Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort JR. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 2004;137:572–574.
- Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74:179–185.
- Pratt MD, Mufti A, Lipson J, et al. Patch test reactions to corticosteroids: retrospective analysis from the North American contact dermatitis group 2007–2014. Dermatitis. 2017;28(1):58–63.